Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does HYALURONIDASE Cause Product use issue? 187 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 187 reports of Product use issue have been filed in association with HYALURONIDASE (Phesgo). This represents 16.9% of all adverse event reports for HYALURONIDASE.

187
Reports of Product use issue with HYALURONIDASE
16.9%
of all HYALURONIDASE reports
112
Deaths
167
Hospitalizations

How Dangerous Is Product use issue From HYALURONIDASE?

Of the 187 reports, 112 (59.9%) resulted in death, 167 (89.3%) required hospitalization, and 121 (64.7%) were considered life-threatening.

Is Product use issue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for HYALURONIDASE. However, 187 reports have been filed with the FAERS database.

What Other Side Effects Does HYALURONIDASE Cause?

Fatigue (375) Alopecia (358) Abdominal discomfort (355) Arthralgia (349) Diarrhoea (330) Headache (328) Hypertension (325) Blood cholesterol increased (320) Arthropathy (318) Off label use (315)

What Other Drugs Cause Product use issue?

INFLIXIMAB (12,752) DUPILUMAB (10,575) POLYETHYLENE GLYCOL 3350 (9,432) METHOTREXATE (8,185) DICLOFENAC (8,009) RITUXIMAB (6,948) ADALIMUMAB (6,379) ETANERCEPT (6,062) TOCILIZUMAB (5,944) ABATACEPT (5,915)

Which HYALURONIDASE Alternatives Have Lower Product use issue Risk?

HYALURONIDASE vs HYALURONIDASE-OCSQ\OCRELIZUMAB HYALURONIDASE vs HYALURONIDASE \RITUXIMAB HYALURONIDASE vs HYALURONIDASE-ZZXF\PERTUZUMAB\TRASTUZUMAB HYALURONIDASE vs HYDRALAZINE HYALURONIDASE vs HYDRALAZINE\ISOSORBIDE DINITRATE

Related Pages

HYALURONIDASE Full Profile All Product use issue Reports All Drugs Causing Product use issue HYALURONIDASE Demographics